China Universal Asset Management Company’s BridgeBio Pharma BBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.65M | Sell |
38,137
-12
| -0% | -$518 | 0.16% | 125 |
|
|
2025
Q1 | $1.32M | Sell |
38,149
-1,924
| -5% | -$66.5K | 0.12% | 150 |
|
|
2024
Q4 | $1.1M | Buy |
40,073
+3,908
| +11% | +$107K | 0.1% | 149 |
|
|
2024
Q3 | $921K | Buy |
36,165
+14,181
| +65% | +$361K | 0.1% | 144 |
|
|
2024
Q2 | $557K | Sell |
21,984
-11,790
| -35% | -$299K | 0.08% | 135 |
|
|
2024
Q1 | $1.04M | Buy |
33,774
+13,654
| +68% | +$422K | 0.13% | 125 |
|
|
2023
Q4 | $812K | Buy |
20,120
+15,949
| +382% | +$644K | 0.16% | 123 |
|
|
2023
Q3 | $110K | Buy |
4,171
+2,067
| +98% | +$54.5K | 0.03% | 191 |
|
|
2023
Q2 | $36.2K | Buy |
2,104
+54
| +3% | +$929 | 0.01% | 225 |
|
|
2023
Q1 | $34K | Buy |
2,050
+531
| +35% | +$8.8K | 0.01% | 179 |
|
|
2022
Q4 | $11.6K | Buy |
1,519
+131
| +9% | +$998 | ﹤0.01% | 215 |
|
|
2022
Q3 | $14K | Buy |
+1,388
| New | +$14K | 0.01% | 175 |
|